4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-22-049938
Chief Operating Officer sold 17,344 shares at $2.15 ($37,290)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tardio Jason Chief Operating Officer | 2022-09-12 | Sale | −17,344 | $2.15 | $37,290 | 0 | D |
| Open-market sales · 17,344 sh · avg $2.15 · $37,290 | |||||||
Loading xslF345X03/doc4.xml…